"...M&A, restructuring, capital raising and leading the finance function..."
Take your pick. What is his appointment for? I don't think capital raising is in consideration here as IMU is already very well capitalised. So that left M&A, restructuring and finance function. Given the stage that IMU is at, chances of M&A is rather high, I reckon.
Ann: Imugene appoints experienced life sciences CFO Mike Tonroe, page-7
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
